Eurofarma Ventures

Eurofarma Ventures is the corporate venture capital arm of Brazilian pharmaceutical company Eurofarma, focused on investing in early-stage biotechnology startups from its headquarters in São Paulo, Brazil. The firm operates with up to $100 million in committed capital to support disruptive drug discovery and development therapies. It functions alongside its parent organization's broader research and development initiatives, which include a dedicated laboratory housing 600 researchers working on over 400 active projects. The venture unit leverages the scale of Eurofarma, an enterprise with more than 12,000 employees and approximately $1.8 billion in 2023 net sales, which recently expanded by acquiring Genfar and several Latin American assets from Sanofi. Eurofarma Ventures was established in 2023 under the leadership of Eurofarma CEO Maurízio Billi, Vice President of Innovation Martha Penna, and Global Executive Director Rodrigo Pereira.